$AMPY stock - Testing 52 Weeks HighAmplify Energy Corp.BATS:AMPYLylyticsAMPY (Amplify Energy) What is AMPY? AMPY is a small US oil and gas company focused on two core areas; Beta (offshore California) and Bairoil (Rockies). Their current strategy is to sell non-core assets (Oklahoma, East Texas) and go all-in on these core positions. Latest Update (March 2026) They reported Q4 2025 net income of $64.4M, but don't be fooled; the bulk of that came from a one-off asset sale gain (~$54.7M), not from regular operations. Year-end cash was $61M. Proved reserves came in at 38.1 MMBoe with a PV-10 of ~$376M; decent for their size. Key takeaway: earnings look great on the surface, but it's mostly driven by asset sales, not improving business performance. Why are institutions buying? Three main reasons; cheap valuation (single-digit P/E); debt reduction (asset sale proceeds used to pay down debt, credit facility extended to 2028); and reserve value vs enterprise value looks attractive, implying upside if management can grow production from core assets without relying on more one-offs. What could break the thesis? Oil prices drop below ~$55-60/bbl for an extended period; cash flow wouldn't be enough to fund development. Core assets (Beta/Bairoil) fail to deliver meaningful margin improvement. The company is forced to issue equity or take on new debt at unfavorable terms; destroying the balance sheet repair narrative. Revenue and EPS Trend (Last 4 Quarters) Revenue has been declining; Q4 2024: ~$69M, Q1 2025: ~$72M (slight uptick), Q2: ~$68M, Q3: ~$66M, Q4 2025: ~$56.6M (notable drop). EPS was all over the place; $0.13, $0.09, negative, more negative, then a sudden $1.53 in Q4 2025 (entirely driven by the one-off gain). Gross margin is high (~90%+) but operating margin is near zero or negative; meaning corporate costs, interest, and project expenses are eating up nearly all the profit. Risks to Watch Heavy dependence on asset sale proceeds to show strong EPS; if there are no more assets to sell, or they sell at lower prices, earnings collapse. Oil price sensitivity remains high. No recent insider selling (good sign), but potential dilution risk still exists if they need additional capital down the road. Bottom Line AMPY is a turnaround and simplification story; sell the underperformers, focus on core, pay down debt. The thesis holds as long as oil prices stay stable and core assets deliver. But be aware that current earnings are inflated by one-offs; the real test is whether recurring cash flow can meaningfully improve going forward.